Superior survival of young women with malignant melanoma

American Journal of Surgery
M M KemenyH R Menck

Abstract

The Commission on Cancer data from the National Cancer Data Base (NCDB) relating to patients with malignant melanoma are used to examine patterns of long-term survival by patient gender and age, stage of disease, disease morphology, and anatomic subsite. Five calls for data have yielded more than 3,700,000 cases of cancer for the years 1985 through 1993, including 23,341 cases of malignant melanoma between 1985 and 1989, from hospital cancer registries across the US, representing slightly less than a quarter of all melanoma cases diagnosed in the US between 1985 and 1989. Three statements can be made from this data: (1) There is little difference in the frequency of malignant melanoma between men and women with respect to stage of disease or morphology. However, differences between the genders do appear with respect to the anatomic subsite of melanotic tumors. (2) Overall, young women (45 years of age and under) enjoy superior survival rates when compared with older women (55 years of age and older) and men of any age. (3) The survival advantage held by young women is particularly pronounced among patients diagnosed with advanced stage disease. These data suggest that factors present in younger women may be critical in the supe...Continue Reading

References

Aug 1, 1978·Cancer·H M ShawW H McCarthy
Nov 1, 1992·Seminars in Surgical Oncology·C M Balch
Aug 20, 1992·The New England Journal of Medicine·G CocconiP Costa
May 1, 1990·Annals of Surgery·C L SlingluffH F Seigler
Nov 15, 1989·International Journal of Cancer. Journal International Du Cancer·H O AdamiL Bergkvist
Apr 1, 1995·Melanoma Research·A LadányiK Lapis

❮ Previous
Next ❯

Citations

Dec 4, 2012·Clinical & Experimental Metastasis·Judit DobosAndrea Ladányi
Dec 20, 2007·Body Image·Wendy G LichtenthalMichael E Ming
Jul 5, 2001·American Journal of Surgery·C D WohltmannD A Spain
Mar 12, 2010·Pigment Cell & Melanoma Research·Arjen JoosseJan Willem W Coebergh
Mar 3, 2004·Annals of Surgical Oncology·Celia ChaoKelly M McMasters
Jul 13, 2002·American Journal of Clinical Dermatology·Pearon G Lang
Jul 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K F KölmelC Seebacher
Apr 2, 2014·Mayo Clinic Proceedings·Elizabeth Ann L EnningaSvetomir N Markovic
Sep 24, 2004·International Journal of Cancer. Journal International Du Cancer·Judit DobosAndrea Ladányi
Dec 15, 2010·The Journal of Investigative Dermatology·Arjen JoosseUNKNOWN Munich Melanoma Group
Sep 28, 2012·The British Journal of Dermatology·V de GiorgiD Massi
Oct 15, 2013·The Laryngoscope·Paolo M ArceEric J Lentsch
Feb 19, 2000·Hematology/oncology Clinics of North America·M M KemenyB J O'Hea
Jun 28, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Federica TomaoSilverio Tomao
Apr 7, 2015·International Journal of Women's Dermatology·Mi Ryung RohHensin Tsao
Nov 20, 2014·Annals of Surgical Oncology·Arjen JoosseJohn F Thompson
Feb 24, 2015·Frontiers in Oncology·Roxana S Dronca, Haidong Dong
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arjen JoosseEsther de Vries
Jan 10, 2018·International Journal of Cancer. Journal International Du Cancer·Bo LiQingyi Wei
Sep 8, 2017·Cancer Medicine·Elizabeth Ann L EnningaRoxana S Dronca
May 27, 2017·Applied Immunohistochemistry & Molecular Morphology : AIMM·Dalma Udovicic-GagulaMirsad Doric
Jan 17, 2007·Shock·Michael FrinkFrank Hildebrand
May 11, 2011·Expert Review of Anticancer Therapy·Vincenzo de GiorgiDaniela Massi
Feb 28, 2020·Journal of Women's Health·Tina J HiekenElizabeth B Habermann
Jul 11, 2020·Cancers·Maria BellenghiGianfranco Mattia
Jun 1, 2019·Current Epidemiology Reports·Matthew Robert SchwartzMarianne Berwick
Feb 12, 2017·The Australasian Journal of Dermatology·Sarah Kym Morton, Adam Park Morton
Nov 23, 2019·Cells·Emi DikaFederica Scarfì
Jul 24, 2020·Oncology and Therapy·Francesca MorgeseRossana Berardi
Aug 13, 2015·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Emanuele CrocettiCarlotta Buzzoni
Dec 2, 2020·International Journal of Molecular Sciences·Kevinn Eddy, Suzie Chen
Apr 9, 2010·Melanoma Research·Konstantinos G LasithiotakisClaus Garbe
Feb 14, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rachel I VogelDeAnn Lazovich
Jul 25, 2014·Archives of Biochemistry and Biophysics·Adi Nosrati, Maria L Wei
Mar 28, 2018·Journal of the American Academy of Dermatology·Jeffrey F ScottJeremy S Bordeaux
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A D WagnerB C Özdemir
Apr 17, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E de VriesJ W W Coebergh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Oncology
Marianne Berwick, A C Halpern
Current Opinion in Oncology
V G Vogel, R E Fisher
© 2022 Meta ULC. All rights reserved